Photo taken from Bartomeu Massuti/X
Jun 1, 2024, 21:13
Bartomeu Massuti on Optó-TROP 01 Lung study at ASCO24
Bartomeu Massuti, Associate Professor at Miguel Hernandez University of Elche, shared a post on X:
“Optó-TROP 01 Lung study: Sacitumumab-Tirumoten plus Immunity-Checkpoint-Inhibitor approach in pretreated NSCLC at ASCO24: interesting results but development continues with Pembrolizumab.”
Source: Bartomeu Massuti/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 06:52
Mar 29, 2025, 06:37
Mar 29, 2025, 06:23
Mar 29, 2025, 06:05
Mar 29, 2025, 04:55
Mar 29, 2025, 04:16